CoronaCentral
Dashboard
Recent
Epidemiology
Forecasting & Modelling
Infection Reports
Transmission
Contact Tracing
Prevalence
Prevention
Surveillance
Clinical
Clinical Reports
Risk Factors
Long Haul
Pediatrics
Medical Specialties
Recommendations
Imaging
Diagnostics
Healthcare Workers
Biology
Molecular Biology
Immunology
Model Systems & Tools
Non-human
Treatment
Therapeutics
Drug Targets
Vaccines
Clinical Trials
Medical Devices
Psychology
Policy
Health Policy
Communication
Inequality
Education
Other Articles
Reviews
Meta-analysis
Comments & Editorials
CDC Weekly Reports
Book Chapters
News
Non-medical
Retractions
Misinformation
Mentions
Drugs
Genes or Proteins
Genetic Variation
Locations
Medical Specialties
Prevention Methods
Risk Factors
Species
Symptoms
Test Types
Transmission Types
Vaccine Types
Viral Lineages
FAQs
Feedback
Select virus of interest
Therapeutics
Share
Research studying the use of new and existing drugs for combating the virus
Published and Preprint Papers
Filter
Export
Drugs
Title
Engineered Nanovesicles Expressing Bispecific Single Chain Variable Fragments to Protect against SARS-CoV-2 Infection.
ritonavir
Activation of PXR causes drug interactions with Paxlovid in transgenic mice.
Azvudine reduces the in-hospital mortality of COVID-19 patients: A retrospective cohort study.
atorvastatin
,
rosuvastatin
A Retrospective Cohort Study Assessing the Impact of Statin Therapy on Hospital Length of Stay and Inpatient Mortality in COVID-19 Patients.
Upamostat: a serine protease inhibitor for antiviral, gastrointestinal and anticancer indications.
heparin
What is the Optimal Treatment Regimen of Low-MolecularWeight Heparin in Coronavirus Disease 2019 Pneumonia?
Human monoclonal antibody F61 nasal spray effectively protected high-risk populations from SARS-CoV-2 variants during the COVID-19 pandemic from late 2022 to early 2023 in China.
Do disease-modifying antirheumatic drugs and non-steroidal anti-inflammatory drugs increase the burden on ankylosing spondylitis patients with mild-moderate COVID-19? evidence from a retrospective cohort study.
Probiotics for the prevention and treatment of COVID-19: a rapid systematic review and meta-analysis.
Influenza A virus replication has a stronger dependency on Raf/MEK/ERK signaling pathway activity than SARS-CoV-2.
10
15
20
25
30